Zacks Investment Research upgraded shares of INOGEN INC (INGN) from NEUTRAL to OUTPERFORM on December 18, 2014, with a target price of $26.80.
Inogen, Inc. is a medical technology company. It offers oxygen concentrator, cart, carry bags, backpacks, external battery chargers and universal power supply for obstructive pulmonary disease patients. The Company's products include Inogen One G3 and Inogen One G2. It sells its products in the United States and internationally. Inogen, Inc. is headquartered in Goleta, California.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on INOGEN INC (INGN),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment